Corcept Therapeutics Inc. CORT

$114.47 +3.58% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 4 2026-08-14 View →
4 4 2026-08-12 View →
4 4 2026-08-12 View →
4 4 2026-08-06 View →
4 4 2026-08-05 View →
4 4 2026-08-05 View →
4 4 2026-08-03 View →
10-Q 10-Q 2026-07-29 View →
8-K 8-K 2026-07-29 View →
4 4 2026-07-17 View →
4 4 2026-07-17 View →
4 4 2026-07-08 View →
4 4 2026-07-08 View →
4 4 2026-07-06 View →
4 4 2026-06-18 View →
4 4 2026-06-18 View →
8-K 8-K 2026-06-17 View →
4 4 2026-06-17 View →
4 4 2026-06-04 View →
4 4 2026-06-03 View →
4 4 2026-06-03 View →
4 4 2026-06-03 View →
4 4 2026-06-03 View →
4 4 2026-06-03 View →
8-K 8-K 2026-06-03 View →
4 4 2026-06-02 View →
4 4 2026-05-29 View →
4 4 2026-05-29 View →
4 4 2026-05-29 View →
8-K 8-K 2026-05-28 View →
4 Insider transaction 2026-05-26 View →
4 4 2026-05-26 View →
4 4 2026-05-26 View →
4 4 2026-05-26 View →
4 4 2026-05-26 View →
4 4 2026-05-26 View →
4 4 2026-05-26 View →
4 4 2026-05-15 View →
4 4 2026-05-07 View →
4 4 2026-05-05 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$114.47
Market Cap
$12.13 billion
52-Week Range
$28.66 $122.21
Average Volume
1.24 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.